Did you mean diarrheal and kidney disease?
Overview
Filspari is approved by the U.S. Food and Drug Administration (FDA) to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression. The drug is…